• Share
  • Email
  • Print

Michael H. Hutson

Associate
+1.704.331.7449
Fax +1.704.353.3149
Mr. Hutson is an associate in the firm’s corporate practice group and focuses his practice on securities, mergers and acquisitions, private equity, and general corporate law matters across a wide range of industries, including life sciences, financial and business services, and manufacturing.

Mr. Hutson also focuses a significant portion of his practice on emerging growth and venture capital transactions, advising large global financial institutions and other corporate clients on early-stage investments in leading fintech and other venture-backed companies, including advising on matters regarding compliance with the Bank Holding Company Act of 1956.

Mr. Hutson also regularly advises public and private clients on transactional, securities and corporate matters, including mergers and acquisitions, public and private securities offerings, reporting requirements under the Securities Exchange Act of 1934 and compliance with stock exchange rules.

Professional Background

Prior to law school, Mr. Hutson worked at the North Carolina Republican Party as an assistant director for state house campaigns.

Professional/Civic Activities

  • Member, Board of Directors and Volunteer Tutor, Heart Math Tutoring
  • Member, Succession Charlotte
  • Member, Charlotte Symphony Orchestra PULSE Young Affiliates Group
Mergers and Acquisitions
Strategic
  • Advised Swedish-based leading global provider of security and surveillance products and services in connection with spin-off asset and equity acquisition of the North American electronic security services business of Diebold (NYSE: DBD) and subsequent spin-off equity acquisition of the public safety and security division of Kratos Defense & Security Solutions, Inc. (NASD: KTOS).
  • Advised Exact Sciences Corporation (NASD: EXAS), a leading molecular diagnostics company focused on the early detection and prevention of some of the deadliest forms of cancer, on its acquisition of Biomatrica, Inc., a San Diego-based biotechnology company specializing in the collection and preservation of biological materials.
Private Equity
  • Advised private equity firm Carousel Capital on buy-side and sell-side transactions, including its acquisition of Apex Analytix, a Greensboro, North Carolina-based leading provider of audit, recovery and compliance technology and services to global Fortune 1000 companies, and its sale of Mergent, a Fort Mill, South Carolina-based leading provider of critical business and financial data on publicly listed and private companies:
  • Advised private equity firm Ballast Point Ventures on the sale of KBI Biopharma, a Morrisville, North Carolina-based a provider of fully integrated, out-sourced drug development and biomanufacturing services to the pharmaceutical and biotechnology industries and the concurrent spinoff and subsequent sale of kSep Systems, a Morrisville, North Carolina-based a provider of automated single-use centrifugation bioprocessing equipment and disposables sold into the areas of recombinant therapeutics, cell therapy and vaccines manufacturing.
  • Advised private-equity sponsored ScentAir Holdings, Inc., a Charlotte, North Carolina-based leading global provider of commercial and residential scent technologies and marketing solutions, on its sale to Parthenon Capital Partners.
  • Advised private equity firm Watermill Group on the sale of C&M Corporation, a Wauregan, Connecticut-based integrated manufacturer of bulk cable, coil cords and cable assembles.
Emerging Growth and Venture Capital
Financial Institution Representation
  • Advised a subsidiary of Goldman Sachs & Co.(NYSE: GS) as an investor in equity financing transactions for leading fintech companies:
    • Aquilon: Developer of proprietary trading settlement software for energy and natural resources trading platforms.
    • BitGo: Market leader in institutional-grade cryptocurrency investment services, providing institutional investors with security, compliance and custodial solutions for blockchain-based currencies.
    • Even Financial: Online consumer finance recommendation engine and acquisition platform.
    • Nav: Online consumer and small business finance platform providing small business owners with credit management and monitoring tools and access to financing.
    • Rabbet: Leading online construction finance platform for construction lenders and real estate developers that intelligently parses documents and connects information between transaction participants.
    • Veem: Leading online global payments platform allowing businesses to send and receive payments in local currency worldwide using SWIFT, treasury and cryptocurrency.
    • Unqork: Leading provider of SaaS platform technology facilitating the digitization of sales for the insurance and financial services industry. 
  •  Advised a subsidiary of Wells Fargo & Company (NYSE: WFC) as an investor in equity financing transactions for leading fintech companies:
    • Axoni: New York-based technology firm that specializes in blockchain infrastructure, distributed application development and workflow automation tools to global financial institutions and capital markets infrastructure companies.
    • Blend: Leading developer of consumer lending software for global financial institutions.
    • H2O: Open source software and artificial intelligence company and developer of artificial intelligence platforms for Fortune 500 companies.
    • SigFig: Developer of consumer investment and portfolio management solutions providing investment recommendations based upon client trading patterns, portfolios and risk profiles.
    • OpenFin: Developer of industry-leading operating system providing desktop workspaces that allow financial services firms, banks and others to run and develop applications addressing financial needs.
  • Advised five of the largest U.S. commercial banks, Capital One, Fifth Third, PNC, TD Bank and Well Fargo, on their strategic investment in Transactis, a leading provider of electronic billing and payment solutions headquartered in New York City.
  • Regularly advise a startup accelerator team and an early-stage, technology focused incubator investment team within Wells Fargo & Company (NYSE: WFC) as pre-seed and seed investors in a number of equity and convertible debt financings of FinTech and other technology companies in the financial services, real estate and consumer goods industries.
Other Venture Capital and Growth Equity Representations
  • Advised Information Builders, Inc., a New York-based leading provider of business intelligence, analytics and data management solutions, in connection with a growth equity investment by Goldman Sachs and Bregal Sagemount and second-step issuer tender offer among large stockholder base.
  • Represented Washington D.C.-based early stage credit card and consumer financial services company in its Series A and Series B financings
  • Regularly represent a variety of companies in connection with general equity investment and corporate law advice.
Securities and Capital Markets
  • Represented Exact Sciences Corporation (NASDAQ:EXAS), a leading molecular diagnostics company focused on the early detection and prevention of some of the deadliest forms of cancer in multiple follow-on public equity offerings yielding over $235,000,000 in net proceeds and in multiple public convertible debt and exchange offerings yielding over $1 billion in net proceeds.
  • Represented Winston-Salem, North Carolina-based Primo Water Corporation (NASDAQ: PRMW), North America’s leading single source provider of multi-gallon purified bottled water, self-service refill drinking water and water dispensers sold through major retailers in the United States and Canada, on a follow-on public equity offering yielding over $60 million in net proceeds, as well as in connection with Primo Water’s acquisition of Glacier Water Services and related registration statement on Form S-4 and other SEC filings.
  • Represented manufacturer of advanced energy storage and power electronics systems in multiple follow-on public offerings yielding over $25,000,000 in net proceeds.
  • Regularly represents a variety of public companies in connection with periodic filings with the Securities and Exchange Commission, including annual and quarterly reports, annual proxy statements and Section 16 filings, and compliance with stock exchange rules.